Suppr超能文献

肺炎衣原体(衣原体属TWAR株)的体外药敏试验

In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

作者信息

Chirgwin K, Roblin P M, Hammerschlag M R

机构信息

Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.

出版信息

Antimicrob Agents Chemother. 1989 Sep;33(9):1634-5. doi: 10.1128/AAC.33.9.1634.

Abstract

The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.

摘要

测定了从纽约布鲁克林分离出的两株肺炎衣原体临床分离株对四环素、红霉素、磺胺甲恶唑、环丙沙星以及三种新型大环内酯类药物——阿奇霉素、克拉霉素和罗红霉素的体外敏感性。克拉霉素是所测试药物中活性最强的,其次是其他大环内酯类药物、四环素和环丙沙星。

相似文献

2
The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR).
J Antimicrob Chemother. 1991 Feb;27 Suppl A:43-5. doi: 10.1093/jac/27.suppl_a.43.
4
In vitro drug susceptibility of Chlamydia sp. strain TWAR.沙眼衣原体TWAR株的体外药物敏感性
Antimicrob Agents Chemother. 1988 Feb;32(2):257-8. doi: 10.1128/AAC.32.2.257.

引用本文的文献

1
Antibiotics for secondary prevention of coronary heart disease.用于冠心病二级预防的抗生素。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD003610. doi: 10.1002/14651858.CD003610.pub4.
8
In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
Antimicrob Agents Chemother. 1993 Apr;37(4):801-3. doi: 10.1128/AAC.37.4.801.
9
Chlamydia pneumoniae.肺炎衣原体
Thorax. 1993 Jan;48(1):1-4. doi: 10.1136/thx.48.1.1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验